Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days £260.00 £353.00 Friday, 10th May 2024 HCM.L stock ended at £352.00. This is 13.55% more than the trading day before Thursday, 9th May 2024. During the day the stock fluctuated 3.22% from a day low at £342.00 to a day high of £353.00.
90 days £202.50 £353.00
52 weeks £173.60 £353.00

Historical Hutchison China Meditech Ltd ADR (Sponsored) prices

Date Open High Low Close Volume
Aug 31, 2023 £244.00 £248.50 £238.00 £238.00 24 009
Aug 30, 2023 £223.50 £223.50 £223.50 £223.50 0
Aug 29, 2023 £238.00 £251.00 £237.00 £244.75 63 230
Aug 25, 2023 £226.51 £226.51 £220.24 £223.50 27 641
Aug 24, 2023 £220.00 £235.00 £220.00 £226.00 157 600
Aug 23, 2023 £220.00 £220.00 £210.85 £213.00 31 999
Aug 22, 2023 £210.00 £214.58 £207.50 £211.50 102 774
Aug 21, 2023 £214.50 £215.00 £206.85 £208.00 13 717
Aug 18, 2023 £210.00 £224.08 £206.00 £210.50 26 708
Aug 17, 2023 £217.50 £217.50 £214.54 £217.75 10 387
Aug 16, 2023 £219.50 £220.93 £214.00 £218.75 21 643
Aug 15, 2023 £224.00 £228.00 £215.68 £219.00 67 710
Aug 14, 2023 £219.00 £224.00 £214.50 £218.50 78 307
Aug 11, 2023 £222.00 £232.63 £213.50 £222.00 82 389
Aug 10, 2023 £227.50 £235.50 £223.00 £228.75 49 581
Aug 09, 2023 £227.50 £230.38 £222.83 £227.50 21 706
Aug 08, 2023 £220.00 £236.50 £216.40 £226.50 177 124
Aug 07, 2023 £218.00 £232.10 £210.50 £216.00 201 211
Aug 04, 2023 £246.50 £257.50 £242.50 £256.25 90 688
Aug 03, 2023 £229.50 £256.60 £229.50 £252.00 196 326
Aug 02, 2023 £230.00 £235.40 £224.00 £225.75 28 294
Aug 01, 2023 £226.50 £243.50 £225.00 £241.25 203 603
Jul 31, 2023 £229.00 £234.85 £221.50 £223.25 39 381
Jul 28, 2023 £232.00 £238.15 £228.00 £229.75 36 057
Jul 27, 2023 £222.50 £226.10 £221.80 £223.00 55 673
Click to get the best stock tips daily for free!

About Hutchison China Meditech Ltd ADR (Sponsored)

Hutchison China Meditech Ltd ADR (Sponsored) HUTCHMED (China) Limited discovers, develops, and commercializes targeted therapeutics and immunotherapies for cancer and immunological diseases in HongKong and internationally. It operates in Oncology/Immunology and Other Ventures segments. The company develops Savolitinib, an inhibitor for non-small cell lung cancer (NSCLC), papillary and renal cell carcinoma, colorectal cancer (CRC), and gastric cancer (GC); and Fruquintinib, an inhibitor for ... HCM.L Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT